NICE chief: CER can have 'big impact' even without cost analysis
The chief executive of the British health system's National Institute for Health and Clinical Excellence (NICE) said comparative effectiveness research that lacks cost analysis could still have a positive impact on health care. He was referring to the Patient-Centered Outcomes . . .
You've followed a link to an article or document on InsideHealthPolicy.com.
There are three ways you can access this content.
Subscriber Login
If you are an InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:
Take A Trial Subscription
If you haven't already had a trial subscription to InsideHealthPolicy.com, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.
Buy This Article
You can also buy this and other individual InsideHealthPolicy.com articles by going to the InsideHealthPolicy.com NewsStand. Articles are $5 apiece. We'll even give you your first download free.
Here's a direct link to this article on the NewsStand.